These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Mutation survey of the optic atrophy 1 gene in 193 Chinese families with suspected hereditary optic neuropathy. Chen Y; Jia X; Wang P; Xiao X; Li S; Guo X; Zhang Q Mol Vis; 2013; 19():292-302. PubMed ID: 23401657 [TBL] [Abstract][Full Text] [Related]
6. Pure and syndromic optic atrophy explained by deep intronic OPA1 mutations and an intralocus modifier. Bonifert T; Karle KN; Tonagel F; Batra M; Wilhelm C; Theurer Y; Schoenfeld C; Kluba T; Kamenisch Y; Carelli V; Wolf J; Gonzalez MA; Speziani F; Schüle R; Züchner S; Schöls L; Wissinger B; Synofzik M Brain; 2014 Aug; 137(Pt 8):2164-77. PubMed ID: 24970096 [TBL] [Abstract][Full Text] [Related]
7. OPA1: How much do we know to approach therapy? Del Dotto V; Fogazza M; Lenaers G; Rugolo M; Carelli V; Zanna C Pharmacol Res; 2018 May; 131():199-210. PubMed ID: 29454676 [TBL] [Abstract][Full Text] [Related]
8. A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy. Thiselton DL; Alexander C; Taanman JW; Brooks S; Rosenberg T; Eiberg H; Andreasson S; Van Regemorter N; Munier FL; Moore AT; Bhattacharya SS; Votruba M Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1715-24. PubMed ID: 12036970 [TBL] [Abstract][Full Text] [Related]
9. The prevalence and natural history of dominant optic atrophy due to OPA1 mutations. Yu-Wai-Man P; Griffiths PG; Burke A; Sellar PW; Clarke MP; Gnanaraj L; Ah-Kine D; Hudson G; Czermin B; Taylor RW; Horvath R; Chinnery PF Ophthalmology; 2010 Aug; 117(8):1538-46, 1546.e1. PubMed ID: 20417570 [TBL] [Abstract][Full Text] [Related]
10. eOPA1: an online database for OPA1 mutations. Ferré M; Amati-Bonneau P; Tourmen Y; Malthièry Y; Reynier P Hum Mutat; 2005 May; 25(5):423-8. PubMed ID: 15832306 [TBL] [Abstract][Full Text] [Related]
11. OPA1 mutations associated with dominant optic atrophy influence optic nerve head size. Barboni P; Carbonelli M; Savini G; Foscarini B; Parisi V; Valentino ML; Carta A; De Negri A; Sadun F; Zeviani M; Sadun AA; Schimpf S; Wissinger B; Carelli V Ophthalmology; 2010 Aug; 117(8):1547-53. PubMed ID: 20417568 [TBL] [Abstract][Full Text] [Related]
12. Autophagy controls the pathogenicity of OPA1 mutations in dominant optic atrophy. Kane MS; Alban J; Desquiret-Dumas V; Gueguen N; Ishak L; Ferre M; Amati-Bonneau P; Procaccio V; Bonneau D; Lenaers G; Reynier P; Chevrollier A J Cell Mol Med; 2017 Oct; 21(10):2284-2297. PubMed ID: 28378518 [TBL] [Abstract][Full Text] [Related]
13. A novel OPA1 mutation causing variable age of onset autosomal dominant optic atrophy plus in an Australian family. Ahmad KE; Davis RL; Sue CM J Neurol; 2015 Oct; 262(10):2323-8. PubMed ID: 26194196 [TBL] [Abstract][Full Text] [Related]
14. A frameshift mutation in exon 28 of the OPA1 gene explains the high prevalence of dominant optic atrophy in the Danish population: evidence for a founder effect. Thiselton DL; Alexander C; Morris A; Brooks S; Rosenberg T; Eiberg H; Kjer B; Kjer P; Bhattacharya SS; Votruba M Hum Genet; 2001 Nov; 109(5):498-502. PubMed ID: 11735024 [TBL] [Abstract][Full Text] [Related]
19. First submicroscopic inversion of the OPA1 gene identified in dominant optic atrophy - a case report. Weisschuh N; Mazzola P; Heinrich T; Haack T; Wissinger B; Tonagel F; Kelbsch C BMC Med Genet; 2020 Nov; 21(1):236. PubMed ID: 33243194 [TBL] [Abstract][Full Text] [Related]